ProfileGDS5678 / 1446437_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 7% 7% 7% 7% 8% 10% 31% 7% 7% 7% 7% 7% 7% 7% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.182487
GSM967853U87-EV human glioblastoma xenograft - Control 22.156127
GSM967854U87-EV human glioblastoma xenograft - Control 32.163447
GSM967855U87-EV human glioblastoma xenograft - Control 42.113477
GSM967856U87-EV human glioblastoma xenograft - Control 52.132448
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.2884110
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.7444331
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.137917
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.13167
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.150017
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.134587
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.135247
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.155727
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.14587